Related references
Note: Only part of the references are listed.Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site
Moufida Ben Nasr et al.
ACTA DIABETOLOGICA (2015)
β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection
M. M. El Khatib et al.
GENE THERAPY (2015)
Co-transplantation of Human Pancreatic Islets With Post-migratory Neural Crest Stem Cells Increases β-Cell Proliferation and Vascular And Neural Regrowth
Liza Grapensparr et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Hydrogen sulphide as a novel therapy to ameliorate cyclosporine nephrotoxicity
Gwyn Lee et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Risk Factors for Bloodstream Infection After Living-donor Liver Transplantation in Children
Kensuke Shoji et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Novel immunological strategies for islet transplantation
Sara Tezza et al.
PHARMACOLOGICAL RESEARCH (2015)
Coaggregates of Regulatory T Cells and Islet Cells Allow Long-term Graft Survival in Liver Without Immunosuppression
Naohiro Takemoto et al.
TRANSPLANTATION (2015)
PD-1/PD-L1 Costimulatory Pathway-induced Mouse Islet Transplantation Immune Tolerance
T. Li et al.
TRANSPLANTATION PROCEEDINGS (2015)
Remote ischaemic conditioning on recipients of deceased renal transplants, effect on immediate and extended kidney graft function: a multicentre, randomised controlled trial protocol (CONTEXT)
Nicoline V. Krogstrup et al.
BMJ OPEN (2015)
Damage Control as a Strategy to Manage Postreperfusion Hemodynamic Instability and Coagulopathy in Liver Transplant
Joseph DiNorcia et al.
JAMA SURGERY (2015)
Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function
Louisa E. Jeffery et al.
PLOS ONE (2015)
Pig to rat cell transplantation: reduced cellular and antibody responses to xenografts overexpressing PD-L1
Annegret Plege-Fleck et al.
XENOTRANSPLANTATION (2014)
Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection
Andrea Vergani et al.
DIABETES (2013)
Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice
D. M. Xu et al.
DIABETOLOGIA (2012)
Impact of Islet Transplantation on Diabetes Complications and Quality of Life
Roberto Bassi et al.
CURRENT DIABETES REPORTS (2011)
Targeting the CXCR4-CXCL12 Axis Mobilizes Autologous Hematopoietic Stem Cells and Prolongs Islet Allograft Survival via Programmed Death Ligand 1
Paolo Fiorina et al.
JOURNAL OF IMMUNOLOGY (2011)
Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation
S. H. Huang et al.
DIABETOLOGIA (2010)
Local Expression of B7-H4 by Recombinant Adenovirus Transduction in Mouse Islets Prolongs Allograft Survival
Xiaojie Wang et al.
TRANSPLANTATION (2009)
Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy
Jun Yang et al.
CIRCULATION (2008)
Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice
Mohammed Javeed I. Ansaria et al.
CLINICAL IMMUNOLOGY (2008)
Optimization of glucose level to determine the stimulation index of isolated rat islets
Naoaki Sakata et al.
PANCREAS (2008)
Mechanisms of PDL-1 mediated regulation of autoimmune diabetes
Indira Guleria et al.
CLINICAL IMMUNOLOGY (2007)
Characterization of donor dendritic cells and enhancement of dendritic cell efflux with cc-chemokine ligand 21 - A novel strategy to prolong islet allograft survival
Paolo Fiorina et al.
DIABETES (2007)
Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival
Jean Dudler et al.
TRANSPLANTATION (2006)
Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets
T Linn et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Tissue expression of PD-L1 mediates peripheral T cell tolerance
ME Keir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo
SE Sandner et al.
JOURNAL OF IMMUNOLOGY (2005)
Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracreal delivery of alloantigen
O Aramaki et al.
TRANSPLANTATION (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation:: relevance for the immune modulatory effect in multiple sclerosis
B Schreiner et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses
SC Liang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival
WD Gao et al.
TRANSPLANTATION (2003)
Programmed death-1 targeting can promote allograft survival
E Özkaynak et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression of programmed death 1 ligands by murine T cells and APC
T Yamazaki et al.
JOURNAL OF IMMUNOLOGY (2002)
Physiological mechanisms of regulating alloimmunity:: Cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size
M Sho et al.
JOURNAL OF IMMUNOLOGY (2002)
CD28-independent costimulation of T cells in alloimmune responses
A Yamada et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
